Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after
Seyyed Hossein Mousavie Anijdan1, Daryush Moslemi2, Reza Reiazi3
1Department of Radiation Technology, Faculty of Allied Medicine, Babol University of Medical Sciences, Babol, Iran.
Journal of Medical Signals and Sensors
|January 1, 2025
Summary
Radiomics patterns from pretreatment CT scans can predict treatment response in locally advanced rectal cancer (LARC). This method aids in evaluating patient response to neoadjuvant chemoradiotherapy (nCRT) and surgery.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Locally advanced rectal cancer (LARC) treatment involves neoadjuvant chemoradiotherapy (nCRT) followed by surgery.
- Assessing treatment response is crucial for patient follow-up.
- Radiomics analysis of pretreatment CT images can offer insights into treatment response.
Purpose of the Study:
- To investigate radiomics patterns from pretreatment CT images in rectal cancer.
- To explore the relationship between radiomics features and treatment response criteria.
- To evaluate the predictive capability of radiomics for treatment response in LARC.
Main Methods:
- Fifty patients with rectal adenocarcinoma undergoing nCRT and surgery were included.
- Radiomics features were extracted from pretreatment CT images.
- Random forests modeling was used to analyze combined clinical and radiomics data.
Main Results:
- The study included 50 patients (46% male, 54% female).
- No significant difference in treatment response was observed based on age or gender.
- Combined clinical and radiomics data achieved high predictive accuracy (AUC 0.97-0.99) for responders and non-responders.
Conclusions:
- Random forests modeling using combined radiomics and clinical data can predict neoadjuvant treatment response in LARC.
- This approach offers an acceptable level of accuracy in identifying responders and non-responders.
- Radiomics holds potential as a non-invasive tool for treatment response assessment in rectal cancer.


